Depression after stroke: A review of the evidence base to inform the development of an integrated care pathway. Part 1: Diagnosis, frequency and impact

Clinical Rehabilitation

Volumn 16, Issue 3, 2002, Pages 231-247

  Turner Stokes, Lynne ^a   Hassan, Nibras ^a  

^a NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; APHASIA; ARTICLE; COGNITIVE DEFECT; COMPUTER AIDED DESIGN; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MEDICAL LITERATURE; MORBIDITY; MORTALITY; NEUROPSYCHOLOGICAL TEST; OUTCOMES RESEARCH; PATIENT CARE; PUBLISHING; RATING SCALE; SOCIAL DISABILITY; STROKE; VALIDATION PROCESS;

CEREBROVASCULAR ACCIDENT; CRITICAL PATHWAYS; DEPRESSIVE DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; PSYCHOLOGICAL TESTS;

EID: 0036250042     PISSN: 02692155     EISSN: None     Source Type: Journal    
DOI: 10.1191/0269215502cr487oa     Document Type: Article

References (94)

1. Management of poststroke depression in older people
2. Medical complications during stroke rehabilitation
3. Treatment issues in poststroke depression
4. Depressive symptoms and increased risk of stroke mortality over a 29-year period
5. Poststroke depression: An examination of the literature
6. Assessment of depression in patients with brain pathology: The case of stroke
7. Epidemiology and treatment of post-stroke depression
8. Antidepressants for depression in people with physical illness (Cochrane review)
9. Depression without sadness: Alternative presentations of depression in late life
10. Diagnosing depression after stroke
11. Fatigue after stroke
12. Intellectual decline after stroke: The Framingham Study
13. Apathy following cerebrovascular lesions
14. The sources of convergence between measures of apathy and depression
15. First year after stroke: Tracking cognitive and affective deficits
16. Relation of lesion location to verbal and nonverbal mood measures in stroke patients
17. Depression after stroke: A hospital treatment survey
18. Are depressive symptoms nonspecific in patients with acute stroke?
19. Vegetative and psychological symptoms associated with depressed mood over the first two years after stroke
20. Neuropsychiatric consequences of stroke
21. Post-stroke depressive disorders: A follow-up study of 103 patients
22. A two-year longitudinal study of post-stroke mood disorders: Findings during the initial evaluation
23. A two year longitudinal study of mood disorders following stroke. Prevalence and duration at six months follow-up
24. Two-year longitudinal study of poststroke mood disorders: Diagnosis and outcome at one and two years
25. Post-stroke depression: Relationships to functional impairment, coping strategies, and rehabilitation outcome
26. Affective illness after stroke
27. Depression among patients with stroke
28. Mood disorder following cerebrovascular accident
29. Prevalence and course of depressive disorders in hospitalized stroke patients
30. The impact of poststroke depression on recovery in activities of daily living over a 2-year follow-up
31. Social and family integration of hemiplegic elderly patients 1 year after stroke
32. Issues in the diagnosis of post-stroke depression
33. Incidence of post-stroke depression during the first year in a large unselected stroke population determined using a valid standardized rating scale
34. Longitudinal assessment of depression and cognitive impairment following stroke
35. Major depression in stroke patients: A 3-year longitudinal study
36. Effects of early treatment of poststroke depression on neuropsychological rehabilitation
37. Functional recovery and social outcome after cerebral infarction in young adults
38. Frequency and clinical determinants of poststroke depression
39. The Sunnybrook stroke study a prospective study of depressive symptoms and functional outcome
40. Poststroke depression correlates with cognitive impairment and neurological deficits
41. Post-stroke depression and functional outcome: A cohort study investigating the influence of depression on functional recovery from stroke
42. Screening for depressive symptoms in the acute phase of stroke
43. Prevalance of depression after stroke: The Perth community study
44. Depressed mood after stroke. A community study of its frequency
45. Mood disorders in long-term survivors of stroke: Associations with brain lesion location and volume
46. Mood disorders in the first year after stroke
47. Depression after stroke: Results of the FINNSTROKE Study
48. Depression in survivors of stroke: A community-based study of prevalence, risk factors and consequences
49. A two-year longitudinal study of post-stroke mood disorders: Dynamic changes in associated variables over the first six months of follow-up
50. A two year longitudinal study of poststroke mood disorders: Prognostic factors related to one and two year outcome
51. Two-year longitudinal study of post-stroke mood disorders: Dynamic changes in correlates of depression at one and two years
52. Clinical depression is associated with impaired recovery from stroke
53. Depression, introversion and mortality following stroke
54. Association of depression with 10-year poststroke mortality
55. The influence of depression, social activity, and family stress on functional outcome after stroke
56. Risk factors for post-stroke depression
57. Functional impairment associated with acute poststroke depression: The Stroke Data Bank study
58. Gender differences in poststroke depression
59. Handicap in stroke survivors
60. The relationship between intellectual impairment and mood disorder in the first year after stroke
61. Depressive disorders in long-term survivors of stroke. Associations with demographic and social factors, functional status, and brain lesion volume
62. Risk factors for post-stroke depression
63. Post-stroke depression and functional recovery in a population-based stroke register. The Finnstroke study
64. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: A placebo-controlled, double-blind study
65. Poststroke depression and anxiety: Different assessment methods result in variations in incidence and severity estimates
66. An inventory for measuring depression
67. Development of a rating scale for primary depressive illness
68. A self-rating depression scale
69. Screening for depression in stroke patients: The reliability and validity of the Center for Epidemiologic Studies Depression Scale
70. Comparison of six depression rating scales in geriatric stroke patients
71. Screening tests for geriatric depression
72. Screening instruments for depression and anxiety following stroke: Experience in the Perth community stroke study
73. Detecting psychiatric morbidity after stroke: Comparison of the GHQ and the HAD Scale
74. Psychological measures: Reliability in the assessment of stroke patients
75. Use of the Nottingham Health Profile with patients after a stroke
76. Screening for depression: Single question versus GDS
77. A new depression scale designed to be sensitive to change
78. Screening for depression after stroke
79. A multi-modal approach to diagnosis of post-stroke depression
80. Development of the Stroke Aphasic Depression Questionnaire
81. The assessment of depression in aphasic stroke patients: The development of the Stroke Aphasic Depression Questionnaire
82. The Post-Stroke Depression Rating Scale: A test specifically devised to investigate affective disorders of stroke patients
83. A specific laboratory test for the diagnosis of melacholia. Standardization, validation and clinical utility
84. Dexamethasone suppression test and depression in a rehabilitation setting
85. Mood, vegetative disturbance, and dexamethasone suppression test after stroke
86. The dexamethasone suppression test and mood following stroke
87. Dexamethasone suppression test and onset of poststroke depression in patients with ischemic infarction
88. The dexamethasone suppression test. An indicator of depression in stroke but not a predictor of rehabilitation outcome
89. Utility of the dexamethasone suppression test in the diagnosis of poststroke depression
90. Dexamethasone suppression test in depressive stroke patients
91. Identification of Beck Depression Inventory items related to multiple sclerosis